Neurogene (NGNE) Stock Chart & Stock Price History $22.54 +1.07 (+4.98%) Closing price 04:00 PM EasternExtended Trading$22.55 +0.01 (+0.04%) As of 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Neurogene Stock Price Performance The Neurogene (NGNE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 50.73%, with a year-to-date return of -1.40%. In the past month, the stock has increased 18.82%, reflecting recent market activity. As of the latest close, Neurogene traded at $21.47 with a market cap of $306.21 million and volume of 142,891 shares. Receive NGNE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurogene and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.18%1 Month Performance+18.82%3 Month Performance+109.29%Year-To-Date Performance-1.40%1 Year Performance-50.73% NGNE Stock Chart for Wednesday, July, 16, 2025 NGNE Chart by TradingView Neurogene Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$22.26$21.47-3.55%$22.84$20.84142,891 shs$306.21 million07/14/2025$21.43$22.26+3.87%$22.82$19.98201,065 shs$317.47 million07/11/2025$21.96$21.43-2.41%$22.20$21.23113,393 shs$305.64 million07/10/2025$21.26$21.96+3.29%$22.06$20.90111,483 shs$313.15 million07/09/2025$20.28$21.26+4.83%$21.44$20.21229,155 shs$303.17 million07/08/2025$19.50$20.28+4.00%$20.80$19.6297,316 shs$289.23 million07/07/2025$20.05$19.50-2.72%$20.55$19.37221,809 shs$278.07 million07/04/2025$20.05$20.05$20.71$19.0175,550 shs$285.88 million07/03/2025$19.75$20.05+1.49%$20.71$19.0175,550 shs$285.84 million07/02/2025$19.19$19.75+2.92%$21.19$19.08240,671 shs$281.64 million Get the Latest News and Ratings for NGNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurogene and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$14.95$19.19+28.36%$21.19$14.651.35 million shs$273.65 million06/30/2025$16.16$14.95-7.49%$16.33$14.93205,526 shs$213.19 million06/27/2025$16.57$16.16-2.47%$16.86$15.90436,968 shs$230.44 million06/26/2025$16.88$16.57-1.84%$17.26$16.30117,117 shs$236.29 million06/25/2025$17.20$16.88-1.86%$17.45$16.5190,358 shs$240.74 million06/24/2025$17.22$17.20-0.12%$18.21$16.55238,961 shs$245.27 million06/23/2025$17.76$17.22-3.04%$18.05$16.8692,384 shs$245.56 million06/20/2025$18.30$17.76-2.95%$18.56$17.70108,535 shs$253.29 million06/19/2025$18.30$18.30$19.57$18.22203,614 shs$260.96 million06/18/2025$18.42$18.30-0.65%$19.57$18.22203,614 shs$260.96 million06/17/2025$18.97$18.42-2.90%$21.43$18.29152,132 shs$262.71 million06/16/2025$19.76$18.97-4.00%$20.66$18.75158,113 shs$270.55 million Related Companies PAHC Stock Price Chart ABCL Stock Price Chart NTLA Stock Price Chart AMPH Stock Price Chart WVE Stock Price Chart AUPH Stock Price Chart ARDX Stock Price Chart ELVN Stock Price Chart VERV Stock Price Chart NAGE Stock Price Chart Receive NGNE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neurogene and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NGNE) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurogene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
